Sonoma Pharmaceuticals Ownership 2024 | Who Owns Sonoma Pharmaceuticals Now?

Overview RevenueFinancials Chart

Institutional Ownership

2.79%

Insider Ownership

1.97%

Retail Ownership

95.24%

Institutional Holders

17.00

Sonoma Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GEODE CAPITAL MANAGEMENT, LLC	0.56%	-	86,644	50,864	142.16%	18,385	Jun 30, 2024
STATE STREET CORP	0.16%	-	24,315	-	-	5,160,000	Jun 30, 2024
HRT FINANCIAL LP	0.14%	-	21,519	21,519	100.00%	4,000	Jun 30, 2024
XTX TOPCO LTD	0.13%	0.00%	19,834	3,371	20.48%	4,209	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.10%	-	15,325	1,852	13.75%	3,252	Jun 30, 2024
UBS GROUP AG	0.08%	-	11,917	11,814	11469.90%	2,527	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	-	8,268	-3,712	-30.98%	1,753	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.02%	-	3,400	3,400	100.00%	722	Jun 30, 2024
BLACKROCK INC.	0.01%	-	2,266	-	-	481	Jun 30, 2024
US BANCORP \DE\	0.00%	-	500	-	-	106	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	200	200	100.00%	42	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	172	128	290.91%	36	Jun 30, 2024
MORGAN STANLEY	0.00%	-	86	-	-	18	Jun 30, 2024
ALLWORTH FINANCIAL LP	0.00%	-	65	-	-	21	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	33	-89	-72.95%	7	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-13,016	-100.00%	-	Jun 30, 2024

Sonoma Pharmaceuticals's largest institutional shareholder is GEODE CAPITAL MANAGEMENT, LLC, holding 0.56% of the company's total share outstanding, currently valued at $18.39K. The top 10 institutional shareholders own together 1.24% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
XTX TOPCO LTD	0.13%	0.00%	19,834	3,371	20.48%	4,209	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.10%	-	15,325	1,852	13.75%	3,252	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	-	8,268	-3,712	-30.98%	1,753	Jun 30, 2024
HRT FINANCIAL LP	0.14%	-	21,519	21,519	100.00%	4,000	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.56%	-	86,644	50,864	142.16%	18,385	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.02%	-	3,400	3,400	100.00%	722	Jun 30, 2024
UBS GROUP AG	0.08%	-	11,917	11,814	11469.90%	2,527	Jun 30, 2024
STATE STREET CORP	0.16%	-	24,315	-	-	5,160,000	Jun 30, 2024
US BANCORP \DE\	0.00%	-	500	-	-	106	Jun 30, 2024
ALLWORTH FINANCIAL LP	0.00%	-	65	-	-	21	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	200	200	100.00%	42	Jun 30, 2024
BLACKROCK INC.	0.01%	-	2,266	-	-	481	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	172	128	290.91%	36	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	33	-89	-72.95%	7	Jun 30, 2024
MORGAN STANLEY	0.00%	-	86	-	-	18	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-13,016	-100.00%	-	Jun 30, 2024

The largest Sonoma Pharmaceuticals shareholder by % of total assets is XTX TOPCO LTD. The company owns 19.83K shares of Sonoma Pharmaceuticals (SNOA), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GEODE CAPITAL MANAGEMENT, LLC	0.56%	-	86,644	50,864	142.16%	18,385	Jun 30, 2024
HRT FINANCIAL LP	0.14%	-	21,519	21,519	100.00%	4,000	Jun 30, 2024
UBS GROUP AG	0.08%	-	11,917	11,814	11469.90%	2,527	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.02%	-	3,400	3,400	100.00%	722	Jun 30, 2024
XTX TOPCO LTD	0.13%	0.00%	19,834	3,371	20.48%	4,209	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.10%	-	15,325	1,852	13.75%	3,252	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	200	200	100.00%	42	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	172	128	290.91%	36	Jun 30, 2024
MORGAN STANLEY	0.00%	-	86	-	-	18	Jun 30, 2024
BLACKROCK INC.	0.01%	-	2,266	-	-	481	Jun 30, 2024
ALLWORTH FINANCIAL LP	0.00%	-	65	-	-	21	Jun 30, 2024
US BANCORP \DE\	0.00%	-	500	-	-	106	Jun 30, 2024
STATE STREET CORP	0.16%	-	24,315	-	-	5,160,000	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	33	-89	-72.95%	7	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	-	8,268	-3,712	-30.98%	1,753	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-13,016	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Sonoma Pharmaceuticals's largest institutional buyer is GEODE CAPITAL MANAGEMENT, LLC. The company purchased 50.86K stocks of SNOA, valued at $18.39K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MILLENNIUM MANAGEMENT LLC	-	-	-	-13,016	-100.00%	-	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	-	8,268	-3,712	-30.98%	1,753	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	33	-89	-72.95%	7	Jun 30, 2024
STATE STREET CORP	0.16%	-	24,315	-	-	5,160,000	Jun 30, 2024
US BANCORP \DE\	0.00%	-	500	-	-	106	Jun 30, 2024
ALLWORTH FINANCIAL LP	0.00%	-	65	-	-	21	Jun 30, 2024
BLACKROCK INC.	0.01%	-	2,266	-	-	481	Jun 30, 2024
MORGAN STANLEY	0.00%	-	86	-	-	18	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	172	128	290.91%	36	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	200	200	100.00%	42	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.10%	-	15,325	1,852	13.75%	3,252	Jun 30, 2024
XTX TOPCO LTD	0.13%	0.00%	19,834	3,371	20.48%	4,209	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.02%	-	3,400	3,400	100.00%	722	Jun 30, 2024
UBS GROUP AG	0.08%	-	11,917	11,814	11469.90%	2,527	Jun 30, 2024
HRT FINANCIAL LP	0.14%	-	21,519	21,519	100.00%	4,000	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.56%	-	86,644	50,864	142.16%	18,385	Jun 30, 2024

As of Jun 30 2024, Sonoma Pharmaceuticals's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -13.02K shares of SNOA, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
QUBE RESEARCH & TECHNOLOGIES LTD	0.02%	-	3,400	3,400	100.00%	722	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	200	200	100.00%	42	Jun 30, 2024

Sonoma Pharmaceuticals's largest new institutional shareholder by number of shares is QUBE RESEARCH & TECHNOLOGIES LTD, purchased 3.40K shares, valued at $722.00, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MILLENNIUM MANAGEMENT LLC	-	-	-	-13,016	-100.00%	-	Jun 30, 2024

Sonoma Pharmaceuticals's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -13.02K shares, valued at -, as of undefined.

Sonoma Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BRIDGEWAY FUNDS INC	0.00%	6,600	-	-	Mar 28, 2024
HUSSMAN INVESTMENT TRUST	0.00%	3,100	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	35,780	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	3,818	-3,818	-50.00%	Mar 31, 2024
Dimensional ETF Trust	0.00%	1,648	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	3,110	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	439	-	-	Jan 31, 2024

Sonoma Pharmaceuticals's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 6.60K shares, compromising 0.00% of its total assets.

Sonoma Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	17	21.43%
31 Mar, 24	14	-12.50%
31 Dec, 23	16	33.33%
30 Sep, 23	12	-20.00%
30 Jun, 23	15	-11.76%
31 Mar, 23	17	30.77%
31 Dec, 22	13	44.44%
30 Sep, 22	9	-10.00%
30 Jun, 22	10	-
31 Mar, 22	10	-9.09%
31 Dec, 21	11	-8.33%
30 Sep, 21	12	-7.69%
30 Jun, 21	13	8.33%
31 Mar, 21	12	-
31 Dec, 20	12	-7.69%
30 Sep, 20	13	62.50%
30 Jun, 20	8	-11.11%
31 Mar, 20	9	-10.00%
31 Dec, 19	10	11.11%
30 Sep, 19	9	-10.00%
30 Jun, 19	10	-

As of 30 Jun 24, 17 institutions are holding Sonoma Pharmaceuticals's shares, representing an increase of 21.43% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	434,996	164.81%
31 Mar, 24	164,265	-45.93%
31 Dec, 23	303,776	141.45%
30 Sep, 23	125,814	-22.31%
30 Jun, 23	161,945	10.38%
31 Mar, 23	146,715	3.00%
31 Dec, 22	142,440	-20.26%
30 Sep, 22	178,621	-3.28%
30 Jun, 22	184,680	7.41%
31 Mar, 22	171,945	-3.02%
31 Dec, 21	177,299	-16.57%
30 Sep, 21	212,504	0.20%
30 Jun, 21	212,090	19.76%
31 Mar, 21	177,098	-2.21%
31 Dec, 20	181,097	-7.65%
30 Sep, 20	196,105	38.69%
30 Jun, 20	141,396	10.47%
31 Mar, 20	127,997	0.16%
31 Dec, 19	127,788	61.66%
30 Sep, 19	79,047	-0.92%
30 Jun, 19	79,785	-

Sonoma Pharmaceuticals (SNOA) has 435.00K shares outstanding as of 30 Jun 24, up 164.81% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	2.79%	122.92%
31 Mar, 24	1.51%	19.42%
31 Dec, 23	2.78%	42.86%
30 Sep, 23	2.55%	11.20%
30 Jun, 23	4.77%	21.40%
31 Mar, 23	4.72%	22.47%
31 Dec, 22	4.58%	13.82%
30 Sep, 22	5.76%	16.24%
30 Jun, 22	5.96%	14.18%
31 Mar, 22	6.48%	19.56%
31 Dec, 21	5.76%	7.00%
30 Sep, 21	9.07%	8.83%
30 Jun, 21	10.13%	12.87%
31 Mar, 21	8.87%	11.39%
31 Dec, 20	8.83%	9.25%
30 Sep, 20	9.77%	16.52%
30 Jun, 20	7.69%	15.87%
31 Mar, 20	6.96%	9.59%
31 Dec, 19	8.52%	23.65%
30 Sep, 19	6.00%	16.33%
30 Jun, 19	6.06%	-

As of 30 Jun 24, Sonoma Pharmaceuticals is held by 2.79% institutional shareholders, representing a 122.92% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	10	100.00%
31 Mar, 24	5	-37.50%
31 Dec, 23	8	300.00%
30 Sep, 23	2	-33.33%
30 Jun, 23	3	-57.14%
31 Mar, 23	7	-12.50%
31 Dec, 22	8	300.00%
30 Sep, 22	2	-50.00%
30 Jun, 22	4	33.33%
31 Mar, 22	3	-25.00%
31 Dec, 21	4	-42.86%
30 Sep, 21	7	40.00%
30 Jun, 21	5	-16.67%
31 Mar, 21	6	200.00%
31 Dec, 20	2	-77.78%
30 Sep, 20	9	200.00%
30 Jun, 20	3	-25.00%
31 Mar, 20	4	-
31 Dec, 19	4	100.00%
30 Sep, 19	2	-80.00%
30 Jun, 19	10	-

10 institutional shareholders have increased their position in SNOA stock as of 30 Jun 24 compared to 5 in the previous quarter (a 100.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	2	-
31 Mar, 24	2	-
31 Dec, 23	2	-50.00%
30 Sep, 23	4	33.33%
30 Jun, 23	3	50.00%
31 Mar, 23	2	-33.33%
31 Dec, 22	3	-
30 Sep, 22	3	50.00%
30 Jun, 22	2	-
31 Mar, 22	2	-50.00%
31 Dec, 21	4	300.00%
30 Sep, 21	1	-80.00%
30 Jun, 21	5	400.00%
31 Mar, 21	1	-66.67%
31 Dec, 20	3	200.00%
30 Sep, 20	1	-50.00%
30 Jun, 20	2	-
31 Mar, 20	2	100.00%
31 Dec, 19	1	-75.00%
30 Sep, 19	4	-
30 Jun, 19	-	-

2 institutional shareholders have reduced their position in SNOA stock as of 30 Jun 24 compared to 2 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	17	21.43%	434,996	164.81%	2.79%	122.92%	10	100.00%	2	-
31 Mar, 24	14	-12.50%	164,265	-45.93%	1.51%	19.42%	5	-37.50%	2	-
31 Dec, 23	16	33.33%	303,776	141.45%	2.78%	42.86%	8	300.00%	2	-50.00%
30 Sep, 23	12	-20.00%	125,814	-22.31%	2.55%	11.20%	2	-33.33%	4	33.33%
30 Jun, 23	15	-11.76%	161,945	10.38%	4.77%	21.40%	3	-57.14%	3	50.00%
31 Mar, 23	17	30.77%	146,715	3.00%	4.72%	22.47%	7	-12.50%	2	-33.33%
31 Dec, 22	13	44.44%	142,440	-20.26%	4.58%	13.82%	8	300.00%	3	-
30 Sep, 22	9	-10.00%	178,621	-3.28%	5.76%	16.24%	2	-50.00%	3	50.00%
30 Jun, 22	10	-	184,680	7.41%	5.96%	14.18%	4	33.33%	2	-
31 Mar, 22	10	-9.09%	171,945	-3.02%	6.48%	19.56%	3	-25.00%	2	-50.00%
31 Dec, 21	11	-8.33%	177,299	-16.57%	5.76%	7.00%	4	-42.86%	4	300.00%
30 Sep, 21	12	-7.69%	212,504	0.20%	9.07%	8.83%	7	40.00%	1	-80.00%
30 Jun, 21	13	8.33%	212,090	19.76%	10.13%	12.87%	5	-16.67%	5	400.00%
31 Mar, 21	12	-	177,098	-2.21%	8.87%	11.39%	6	200.00%	1	-66.67%
31 Dec, 20	12	-7.69%	181,097	-7.65%	8.83%	9.25%	2	-77.78%	3	200.00%
30 Sep, 20	13	62.50%	196,105	38.69%	9.77%	16.52%	9	200.00%	1	-50.00%
30 Jun, 20	8	-11.11%	141,396	10.47%	7.69%	15.87%	3	-25.00%	2	-
31 Mar, 20	9	-10.00%	127,997	0.16%	6.96%	9.59%	4	-	2	100.00%
31 Dec, 19	10	11.11%	127,788	61.66%	8.52%	23.65%	4	100.00%	1	-75.00%
30 Sep, 19	9	-10.00%	79,047	-0.92%	6.00%	16.33%	2	-80.00%	4	-
30 Jun, 19	10	-	79,785	-	6.06%	-	10	-	-	-

Sonoma Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Buy/Sell	Shares	Price	Value	Shares Held
Jul 21, 2023	Dal Poggetto John	officer	Controller	Sell	5,000	$1.15	$5.75K	-
Apr 13, 2023	DVONCH JEROME J	officer	Interim CFO	Sell	-	-	-	31,009
Apr 13, 2023	DVONCH JEROME J	officer	Interim CFO	Sell	27,777	$8.03	$223.05K	-
Apr 13, 2023	DVONCH JEROME J	officer	Interim CFO	Sell	30,000	$4.60	$138.00K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 21, 2024	Trombly Amy Moss	officer	Chief Executive Officer	A-Award	Buy	53,586	-	-	153,586
Jun 21, 2024	Thornton Bruce	officer	Executive Vice President	A-Award	Buy	53,586	-	-	154,411
Jun 21, 2024	DVONCH JEROME J	officer	Chief Financial Officer	A-Award	Buy	53,586	-	-	84,595
Jun 21, 2024	Dal Poggetto John	officer	Controller	A-Award	Buy	15,000	-	-	15,000
Dec 29, 2023	Trombly Amy Moss	officer	Chief Executive Officer	A-Award	Buy	60,000	$0.18	$10.80K	173,648
Dec 29, 2023	Thornton Bruce	officer	Executive VP & COO	A-Award	Buy	60,000	$0.18	$10.80K	176,781
Dec 29, 2023	Dal Poggetto John	officer	Controller	A-Award	Buy	50,000	$0.18	$9.00K	55,000
Dec 29, 2023	DVONCH JEROME J	officer	Interim CFO	A-Award	Buy	60,000	$0.18	$10.80K	117,777
Jul 21, 2023	Dal Poggetto John	officer	Controller		Sell	5,000	$1.15	$5.75K	-
Jul 03, 2023	Trombly Amy Moss	officer	Chief Executive Officer	A-Award	Buy	100,000	-	-	213,648
Jul 03, 2023	Thornton Bruce	officer	Executive Vice President	A-Award	Buy	100,000	-	-	216,781
Apr 13, 2023	DVONCH JEROME J	officer	Interim CFO		Sell	-	-	-	31,009
Apr 13, 2023	DVONCH JEROME J	officer	Interim CFO		Sell	27,777	$8.03	$223.05K	-
Apr 13, 2023	DVONCH JEROME J	officer	Interim CFO		Sell	30,000	$4.60	$138.00K	-
Dec 30, 2022	White Chad Norman	officer	Chief Financial Officer	A-Award	Buy	9,753	-	-	14,753
Dec 30, 2022	White Chad Norman	officer	Chief Financial Officer	A-Award	Buy	9,753	$1.08	$10.53K	14,753
Dec 30, 2022	Weigerstorfer Philippe	director	-	A-Award	Buy	20,000	-	-	50,000
Dec 30, 2022	Weigerstorfer Philippe	director	-	A-Award	Buy	20,000	$1.08	$21.60K	50,000
Dec 30, 2022	Trombly Amy Moss	officer	Chief Executive Officer	A-Award	Buy	40,000	-	-	113,648
Dec 30, 2022	Trombly Amy Moss	officer	Chief Executive Officer	A-Award	Buy	40,000	$1.08	$43.20K	113,648

The last insider sell of Sonoma Pharmaceuticals's stock was made by Dal Poggetto John on Jul 21 2023, selling 5,000 shares at $1.15 per share (valued at $5.75K).

Sonoma Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	4	-	-
Q4 2023	4	-	-
Q3 2023	-	1	-
Q2 2023	2	3	66.67%
Q4 2022	12	1	1200.00%
Q1 2022	6	-	-
Q1 2021	3	-	-
Q3 2020	-	-	-
Q2 2020	2	-	-
Q1 2020	1	-	-
Q4 2019	2	-	-
Q3 2019	-	3	-
Q1 2019	2	23	8.70%
Q4 2018	-	-	-
Q3 2018	2	1	200.00%
Q2 2018	3	-	-
Q1 2018	14	-	-
Q4 2017	11	-	-
Q3 2017	7	-	-
Q2 2017	12	-	-

4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Sonoma Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q4 2022	-	-	-
Q1 2022	-	-	-
Q1 2021	-	-	-
Q3 2020	-	-	-
Q2 2020	-	-	-
Q1 2020	-	-	-
Q4 2019	-	-	-
Q3 2019	-	-	-
Q1 2019	-	-	-
Q4 2018	-	-	-
Q3 2018	-	-	-
Q2 2018	-	-	-
Q1 2018	5	-	-
Q4 2017	7	-	-
Q3 2017	3	-	-
Q2 2017	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Sonoma Pharmaceuticals's stocks.

Sonoma Pharmaceuticals Peer Ownership

Ticker	Company
AKAN	Akanda Corp.
TKNO	Alpha Teknova, Inc.
ACOR	Acorda Therapeutics, Inc.
SBFM	Sunshine Biopharma, Inc.
LFCR	Lifecore Biomedical, Inc.
UPC	Universe Pharmaceuticals INC
GHSI	Guardion Health Sciences, Inc.
ALIM	Alimera Sciences, Inc.
SHPH	Shuttle Pharmaceuticals Holdings, Inc.
DERM	Journey Medical Corporation
PTPI	Petros Pharmaceuticals, Inc.
SXTC	China SXT Pharmaceuticals, Inc.

SNOA Ownership FAQ

Who Owns Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals is owned by institutional shareholders (2.79%), insiders (1.97%), and public (95.24%). The largest institutional shareholder of Sonoma Pharmaceuticals is GEODE CAPITAL MANAGEMENT, LLC (0.56% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.00% of total shares).

Who are the major institutional shareholders of Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals's major institutional shareholders are GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, HRT FINANCIAL LP, XTX TOPCO LTD, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 1.07% of the company's share outstanding.

How many Sonoma Pharmaceuticals shareholders are there?

As of Jun 2024, there are 17 institutional shareholders of Sonoma Pharmaceuticals.

What percentage of Sonoma Pharmaceuticals is owned by GEODE CAPITAL MANAGEMENT, LLC?

GEODE CAPITAL MANAGEMENT, LLC owns 86.64K shares of Sonoma Pharmaceuticals, representing 0.56% of the company's total shares outstanding, valued at $18.38K (as of Jun 2024).

What percentage of Sonoma Pharmaceuticals is owned by STATE STREET CORP?

As of Jun 2024, STATE STREET CORP holds 24.32K shares of Sonoma Pharmaceuticals (SNOA), compromising 0.16% of the company, valued at $5.16M.

What percentage of Sonoma Pharmaceuticals is owned by HRT FINANCIAL LP?

HRT FINANCIAL LP is the third largest holder of Sonoma Pharmaceuticals. The company owns 21.52K of the company's shares outstanding (worth $4K).